HYBRID EVENT:You can Participate either IN-PERSON or virtually through ZOOM from your home/work.
10th World Congress on
CANCER RESEARCH AND THERAPY
Jun 20 - 22, 2024 at Prague, Czech Republic (Hybrid Event)
HYBRID EVENT:You can Participate either IN-PERSON or virtually through ZOOM from your home/work.
After the grand success of previous cancer conferences, we solicit your gracious presence at the “10th World Congress on CANCER RESEARCH AND THERAPY" (WCCRT-2024) which will be conducted during June 20-22, 2024 as a hybrid event at Prague, Czech Republic and virtually. The conference will emphasize the theme “Novel Discoveries in Cancer Research & Treatment”.
Cancer Congress 2024 is now opening a call for sessions, aiming to develop a programme that brings together the very best of innovation and progress happening across the full spectrum of cancer control, at national, regional and global levels.This is a unique opportunity for cancer experts to share their knowledge and experience with the global cancer community, gain visibility and contribute to advancing cancer control.
A special invitation is extended to international colleagues to attend and contribute to the conference.
The important benefits of attending this conference includes:
Mark your calendars now and for more details, please contact us by email @ cancercongress@innovincinternational.com or Tel: +1-408-352-1010
West Virginia University, USA
Genentech, USA
Al-Ahliyya Amman University, Jordan
Institute of Cytopathology, Germany
Cardiff University, United Kingdom
Japanese Society on Inflammation and Metabolism in Cancerl, Japan
University of Kansas Medical Center, USA
Warsaw Medical University, Poland
Baruch S Blumberg Institute, USA
Shanxi cancer hospital, China
University of Bydgoszcz, Poland
Northwell Health Cancer Institute, USA
University of Maryland, Baltimore, USA
Otsuka America Pharmaceuticals, USA
Crown Bioscience, Netherlands
Vall d´Hebron Research Institute, Spain
Cardiff University, United Kingdom
Wayne State University School of Medicine, USA
Aalen University, Germany
Rutgers University, USA
Affiliated Cancer Hospital of Zhengzhou University, China
KAMC-NGHA, Saudi Arabia
University of Nevada, USA
Frankfurt University Hospital, Germany
The Ohio State University, USA
University of texas Health Science at Houston, USA
University of Texas Health Science Center, USA
Nanjing Drum Tower Hospital, China
Praxis für Hämatologie und Onkologie, Germany
Johnson & Johnson, USA
Memorial Sloan Kettering Cancer Center, USA
SBI Pharmaceuticals, Japan
The Uni. of Texas,M.D.Anderson.org, USA
Cranfield University, United Kingdom
Yale University/ yale Cancer Center, USA
Fukushima Medical University, Japan
Shanghai Jiao Tong University School of Medicine, China
Beijing Tiantan Hospital, Capital Medical University, China
Icahn School of Medicine at Mount Sinai, United States
Northern Arizona University, USA
Columbia University Medical Center, Netherlands
Milton S. Hershey Penn state University Medical Center, USA
Don t Miss This Amazing Conference And Opportunities
Overall, the meeting was well organized and managed, the topics were interesting and in general well attended. The breaks and the services were timed and excellent.
I enjoyed speaking at the WCCRT Conference.
I really enjoyed the conference, very insightful presentation. I appreciate the opportunity to present and moderate the session.
Thank you very much for all your help. I enjoyed a lot last week in the 8th World Congress on CANCER RESEARCH AND THERAPY.
Thanks so much for the excellent WCCRT-2023! Many thanks also to all of your help! Yes, I would be very interested in next year's Cancer Congress 2024 in Prague, Czech Republic. Please keep me informed on the event
It was great congress!
I am looking forward to collaborating with you in the near future.
Great meeting, see you soon again
Thank you for giving me opportunity to present my research work. I enjoyed with all the talks.
It was a pleasure to took attendance in the conference. the speakers and studies were wide profile from different perspectives.
The conference was wonderful and it was a pleasure to present our talk